Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
For four generations, the Saliba family has been in the business of building in Los Angeles. The story begins with Naseeb Michael Saliba, an enterprising ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
While I fully supported then, as I do now, the worthy goal of enhancing market efficiency, then-Commissioner Cynthia Glassman and I objected to Reg NMS’s adoption because we believed that the rigidity ...
HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs announced today that David Delia has been selected as the new President and Chief Executive Officer of the Company. Mr. Delia will guide the organization’s ...
Counseling Department hosted its annual Career Day on Friday, December 5. A long-standing tradition at NMS since 2002, Career ...
As we recently discussed, the SEC has a number of significant rule change proposals on the slate right now. One of those proposals involves splitting the old National Best Bid and Offer (NBBO) into ...
Neuroleptic malignant syndrome (NMS) is a reaction to some specific types of medications. It’s characterized by symptoms like very high fever, rigid muscles, and rapid heartbeat. Although rare, NMS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback